Premium
Synthesis, characteristic spectral studies and in vitro antimicrobial and antitumour activities of organotin(IV) complexes of Schiff bases derived from amino‐acids
Author(s) -
Nath Mala,
Yadav Rakesh,
Gielen Marcel,
Dalil Hassan,
de Vos Dick,
Eng G.
Publication year - 1997
Publication title -
applied organometallic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.53
H-Index - 71
eISSN - 1099-0739
pISSN - 0268-2605
DOI - 10.1002/(sici)1099-0739(199709)11:9<727::aid-aoc639>3.0.co;2-x
Subject(s) - chemistry , stereochemistry , cryptococcus neoformans , escherichia coli , aspergillus fumigatus , alanine , schiff base , candida albicans , amino acid , microbiology and biotechnology , biochemistry , biology , gene
Equimolar reactions of dibutyltin(IV) oxide with Schiff bases derived from amino‐acids led to the formation of a new series of dibutyltin(IV) complexes of general formula, Bu 2 SnL [L=dianion of tridentate Schiff bases derived from the condensation of 2‐hydroxy‐1‐naphthaldehyde or acetyl acetone with glycine (L‐1), L ‐β‐alanine (L‐2), DL ‐valine (L‐3), DL ‐4‐aminobutyric acid (L‐4), L ‐methionine (L‐5), L ‐leucine (L‐6) and phenylglycine (L‐7)]. An attempt has been made to prove the structures of the resulting complexes on the basis of elemental analyses, conductance measurements and electronic, IR, multinuclear magnetic resonance ( 1 H, 13 C and 117 Sn) and 119 Sn Mössbauer spectral studies. The complexes have been tested against various bacteria [ Streptococcus faecalis , Klebsiella pneumoniae , Escherichia coli , Pseudomonas aeruginosa , Staphylococcus aureus penicillin resistance (2500 units)] and fungi ( Candida albicans, Cryptococcus neoformans , Sporotrichum schenckii , Trichophyton mentagrophytes and Aspergillus fumigatus ). All the complexes showed moderate activity. The cytotoxicity of a few compounds has been screened in vitro against seven human tumour cell lines, viz. MCF‐7, EVSA‐T, WiDr, IGROV, M19 MEL, A498 and H226. The activities found experimentally were better than those obtained for cisplatin and carboplatin © 1997 John Wiley & Sons, Ltd.